RE: PK models for rich and sparse sampling

From: Paul Hutson Date: June 01, 2004 technical Source: cognigencorp.com
From: Paul Hutson prhutson@pharmacy.wisc.edu Subject: RE: [NMusers] PK models for rich and sparse sampling Date: Tue, June 1, 2004 10:11 am Mark: The use of PRIOR at GSK and by others (DM) suggests that it is a powerful tool that increases the Bayesian modelling capacity of NONMEM. Although I have a copy, it is unclear to me that its use would be acceptable to reviewers in a manuscript, since it is not a documented subroutine. Have any others been successful in using PRIOR in manuscripts? More importantly (Bill), is there any hope in obtaining "official" recognition and documentation of PRIOR? Paul Paul Hutson, Pharm.D. Associate Professor (CHS) UW School of Pharmacy 777 Highland Avenue Madison, WI 53705-2222 Tel: (608) 263-2496 FAX: (608) 265-5421 Pager: (608) 265-7000, #7856
May 28, 2004 Toufigh Gordi PK models for rich and sparse sampling
May 28, 2004 Atul Bhattaram Venkatesh RE: PK models for rich and sparse sampling
May 30, 2004 Mark Sale RE: PK models for rich and sparse sampling
May 30, 2004 Nick Holford RE: PK models for rich and sparse sampling
May 31, 2004 Mark Sale RE: PK models for rich and sparse sampling
May 31, 2004 Atul Bhattaram Venkatesh RE: PK models for rich and sparse sampling
May 31, 2004 Stephen Duffull RE: PK models for rich and sparse sampling
Jun 01, 2004 Paul Hutson RE: PK models for rich and sparse sampling
Jun 01, 2004 Mark Sale RE: PK models for rich and sparse sampling
Jun 01, 2004 William Bachman RE: PK models for rich and sparse sampling
Jun 01, 2004 Mark Sale RE: PK models for rich and sparse sampling
Jun 01, 2004 Stephen Duffull RE: PK models for rich and sparse sampling
Jun 02, 2004 Mark Sale RE: PK models for rich and sparse sampling